Studies conducted to date clearly indicate that IQOS is likely to present less risk of harm compared to smoking
LAUSANNE, Switzerland, March 28 (BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today announces the positive results from an advanced clinical study on IQOS, the company’s first electronically heated tobacco product, published in the peer-reviewed journal Nicotine & Tobacco Research. Conducted in Japan over a three-month period by the well-known clinical research organization, the Osaki Hospital Tokyo Heart Center, the study showed that smokers who switched to IQOS:
Source: Philip Morris International
0 Comments
Leave a Reply. |
Archives
April 2023
Categories |